Ursodeoxycholic acid suppresses mitochondria-dependent programmed cell death induced by sodium nitroprusside in SH-SY5Y cells

Toxicology

Volumn 292, Issue 2-3, 2012, Pages 105-112

  Chun, Hong Sung ^a   Low, Walter C ^b  

^a Chosun University   (South Korea)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Dopaminergic cell; SNP; Ursodeoxycholic acid

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; CASPASE 7; CASPASE 9; CYTOCHROME C; GLUTATHIONE; NEUROPROTECTIVE AGENT; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PEROXYNITRITE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; TRICIRIBINE; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID DERIVATIVE; YOO SOLUTION;

APOPTOSIS; ARTICLE; CELL VIABILITY; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NEUROPROTECTION; PRIORITY JOURNAL;

CELL DEATH; CELL LINE; CHROMONES; DOPAMINERGIC NEURONS; GLUTATHIONE; HUMANS; IMMUNOBLOTTING; MEMBRANE POTENTIAL, MITOCHONDRIAL; MORPHOLINES; NITRIC OXIDE; NITROPRUSSIDE; PEROXYNITROUS ACID; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; URSODEOXYCHOLIC ACID;

EID: 84856111658     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2011.11.020     Document Type: Article

References (37)

1. Amaral J.D., Viana R.J., Ramalho R.M., Steer C.J., Rodrigues C.M. Bile acids: regulation of apoptosis by ursodeoxycholic acid. J. Lipid Res. 2009, 50:1721-1734.
2. Arisawa S., Ishida K., Kameyama N., Ueyama J., Hattori A., Tatsumi Y., Hayashi H., Yano M., Hayashi K., Katano Y., Goto H., Takagi K., Wakusawa S. Ursodeoxycholic acid induces glutathione synthesis through activation of PI3K/Akt pathway in HepG2 cells. Biochem. Pharmacol. 2009, 77:858-866.
3. Cheng J., Wang F., Yu D.F., Wu P.F., Chen J.G. The cytotoxic mechanism of malondialdehyde and protective effect of carnosine via protein cross-linking/mitochondrial dysfunction/reactive oxygen species/MAPK pathway in neurons. Eur. J. Pharmacol. 2011, 650:184-194.
4. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 1999, 13:2905-2927.
5. Drechsel D.A., Patel M. Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease. Free Radic. Biol. Med. 2008, 44:1873-1886.
6. Duan W.M., Rodrigues C.M., Zhao L.R., Steer C.J., Low W.C. Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease. Cell Transplant. 2002, 11:195-205.
7. Gupta S., Kass G.E., Szegezdi E., Joseph B. The mitochondrial death pathway: a promising therapeutic target in diseases. J. Cell. Mol. Med. 2009, 13:1004-1033.
8. Higuchi Y., Yoshimoto T. Arachidonic acid converts the glutathione depletion-induced apoptosis to necrosis by promoting lipid peroxidation and reducing caspase-3 activity in rat glioma cells. Arch. Biochem. Biophys. 2002, 400:133-140.
9. Hofmann A.F. Pharmacology of ursodeoxycholic acid, an enterohepatic drug. Scand. J. Gastroenterol. Suppl. 1994, 204:1-15.
10. Im E., Akare S., Powell A., Martinez J.D. Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt/PKB-dependent survival signaling. Nutr. Cancer 2005, 51:110-116.
11. Janjetovic K., Misirkic M., Vucicevic L., Harhaji L., Trajkovic V. Synergistic antiglioma action of hyperthermia and nitric oxide. Eur. J. Pharmacol. 2008, 583:1-10.
12. Jantas D., Pytel M., Mozrzymas J.W., Leskiewicz M., Regulska M., Antkiewicz-Michaluk L., Lason W. The attenuating effect of memantine on staurosporine-, salsolinol- and doxorubicin-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem. Int. 2008, 52:864-877.
13. Jha N., Jurma O., Lalli G., Liu Y., Pettus E.H., Greenamyre J.T., Liu R.M., Forman H.J., Andersen J.K. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J. Biol. Chem. 2000, 275:26096-26101.
14. Keene C.D., Rodrigues C.M., Eich T., Chhabra M.S., Steer C.J., Low W.C. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:10671-10676.
15. Lapenna D., Ciofani G., Festi D., Neri M., Pierdomenico S.D., Giamberardino M.A., Cuccurullo F. Antioxidant properties of ursodeoxycholic acid. Biochem. Pharmacol. 2002, 64:1661-1667.
16. Lee H.J., Cho H.S., Park E., Kim S., Lee S.Y., Kim C.S., Kim do K., Kim S.J., Chun H.S. Rosmarinic acid protects human dopaminergic neuronal cells against hydrogen peroxide-induced apoptosis. Toxicology 2008, 250:109-115.
17. Merad-Boudia M., Nicole A., Santiard-Baron D., Saille C., Ceballos-Picot I. Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease. Biochem. Pharmacol. 1998, 56:645-655.
18. Miura T., Ouchida R., Yoshikawa N., Okamoto K., Makino Y., Nakamura T., Morimoto C., Makino I., Tanaka H. Functional modulation of the glucocorticoid receptor and suppression of NF-kappaB-dependent transcription by ursodeoxycholic acid. J. Biol. Chem. 2001, 276:47371-47378.
19. Nagatsu T., Sawada M. Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects. J. Neural Transm. Suppl. 2007, 113-120.
20. Nieoullon A. Neurodegenerative diseases and neuroprotection: current views and prospects. J. Appl. Biomed. 2011, 9:173-183.
21. Offen D., Ziv I., Sternin H., Melamed E., Hochman A. Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease. Exp. Neurol. 1996, 141:32-39.
22. Olanow C.W., Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 1999, 22:123-144.
23. Park E.S., Kim S.Y., Na J.I., Ryu H.S., Youn S.W., Kim D.S., Yun H.Y., Park K.C. Glutathione prevented dopamine-induced apoptosis of melanocytes and its signaling. J. Dermatol. Sci. 2007, 47:141-149.
24. Park I.H., Kim M.K., Kim S.U. Ursodeoxycholic acid prevents apoptosis of mouse sensory neurons induced by cisplatin by reducing P53 accumulation. Biochem. Biophys. Res. Commun. 2008, 377:1025-1030.
25. Rodrigues C.M., Ma X., Linehan-Stieers C., Fan G., Kren B.T., Steer C.J. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ. 1999, 6:842-854.
26. Rodrigues C.M., Sola S., Nan Z., Castro R.E., Ribeiro P.S., Low W.C., Steer C.J. Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:6087-6092.
27. Schoemaker M.H., Conde de la Rosa L., Buist-Homan M., Vrenken T.E., Havinga R., Poelstra K., Haisma H.J., Jansen P.L., Moshage H. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 2004, 39:1563-1573.
28. Sharma H., Zhang P., Barber D.S., Liu B. Organochlorine pesticides dieldrin and lindane induce cooperative toxicity in dopaminergic neurons: role of oxidative stress. Neurotoxicology 2010, 31:215-222.
29. Sola S., Castro R.E., Laires P.A., Steer C.J., Rodrigues C.M. Tauroursodeoxycholic acid prevents amyloid-beta peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway. Mol. Med. 2003, 9:226-234.
30. Sola S., Ma X., Castro R.E., Kren B.T., Steer C.J., Rodrigues C.M. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes. J. Biol. Chem. 2003, 278:48831-48838.
31. Thao T.D., Ryu H.C., Yoo S.H., Rhee D.K. Antibacterial and anti-atrophic effects of a highly soluble, acid stable UDCA formula in Helicobacter pylori-induced gastritis. Biochem. Pharmacol. 2008, 75:2135-2146.
32. Tsuruta F., Masuyama N., Gotoh Y. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J. Biol. Chem. 2002, 277:14040-14047.
33. Vairetti M., Ferrigno A., Bertone R., Richelmi P., Berte F., Freitas I. Apoptosis vs. necrosis: glutathione-mediated cell death during rewarming of rat hepatocytes. Biochim. Biophys. Acta 2005, 1740:367-374.
34. Wang J., Fillebeen C., Chen G., Andriopoulos B., Pantopoulos K. Sodium nitroprusside promotes IRP2 degradation via an increase in intracellular iron and in the absence of S nitrosylation at C178. Mol. Cell. Biol. 2006, 26:1948-1954.
35. Wullner U., Seyfried J., Groscurth P., Beinroth S., Winter S., Gleichmann M., Heneka M., Loschmann P., Schulz J.B., Weller M., Klockgether T. Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function. Brain Res. 1999, 826:53-62.
36. Zhang Y., Dawson V.L., Dawson T.M. Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 2000, 7:240-250.
37. Zhang Y., Zhao B. Green tea polyphenols enhance sodium nitroprusside-induced neurotoxicity in human neuroblastoma SH-SY5Y cells. J. Neurochem. 2003, 86:1189-1200.